Hidradenitis Suppurativa clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • A Study of Imsidolimab for the Skin Condition Hidradenitis Suppurativa

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18-75

    Efficacy and Safety of Imsidolimab (ANB019) in Subjects with Hidradenitis Suppurativa

    Sacramento, California and other locations

Last updated: